This clinical policy from the American College of Emergency Physicians addresses key issues for adults presenting to the emergency department with suspected transient ischemic attack. A writing subcommittee conducted a systematic review of the literature to derive evidence-based recommendations to answer the following clinical questions: (1) In adult patients with suspected transient ischemic attack, are there clinical decision rules that can identify patients at very low short-term risk for stroke who can be safely discharged from the emergency department? (2) In adult patients with suspected transient ischemic attack, what imaging can be safely delayed from the initial emergency department workup? (3) In adult patients with suspected transient ischemic attack, is carotid ultrasonography as accurate as neck computed tomography angiography or magnetic resonance angiography in identifying severe carotid stenosis? (4) In adult patients with suspected transient ischemic attack, can a rapid emergency department-based diagnostic protocol safely identify patients at short-term risk for stroke? Evidence was graded and recommendations were made based on the strength of the available data.
INTRODUCTION
Transient ischemic attack (TIA) is part of a spectrum that involves ischemia of the central nervous system. Historically the definition of a TIA has been focal neurologic symptoms that resolve within 24 hours of onset. 1 However, studies have shown that approximately one third of all TIAs have evidence of infarction on neurologic imaging. 2 Thus, the American Heart Association/American Stroke Association (AHA/ASA) in 2009 revised the definition for TIA, using a tissue-based diagnosis: "a transient episode of neurological dysfunction caused by focal brain, spinal cord, or retinal ischemia, without acute infarction." 3 If imaging is unavailable and the symptoms last greater than 24 hours, then patients are classified as having had a clinical stroke. 1 Most TIAs, however, are thought to last fewer than 1 or 2 hours. 3 The incidence of TIA in the United States is approximately 240,000 cases a year. However, the true incidence is likely higher because of patients not reporting their symptoms to their health care provider. 1, 4 The risk of an acute ischemic stroke after a TIA ranges from 3.5% to 10% at 2 days, 5% to 10% at 7 days, and 9.2% to 17% at 90 days. [5] [6] [7] [8] [9] [10] [11] [12] [13] Because approximately 15% of all ischemic strokes are preceded by a TIA, timely evaluation for modifiable conditions that are high-risk, such as carotid stenosis and atrial fibrillation, is important. 1, 4 Because of the lack of a specific diagnostic test for TIA, the diagnosis of TIA can be difficult to distinguish from stroke mimickers, such as seizures, migraines, syncope, peripheral vestibular disturbance, or psychogenic causes.
14 Studies have demonstrated difficulty among neurologists and non-neurologists in identifying patients with TIA, with one study reporting that 60% of patients admitted with an initial diagnosis of a TIA had a final diagnosis of a nonischemic cause for their symptoms such as seizures, migraines, or neuropathy. 15, 16 To help identify TIA, riskstratification tools that were originally developed to identify TIA patients at high short-term risk for stroke have also been evaluated to predict true TIA. 17, 18 Research is also currently under way to evaluate possible biomarkers to help establish the diagnosis of TIA. 19 Evaluation of TIA patients in the emergency department (ED) has been shown to be variable, depending on resources available. Brain neuroimaging in the ED may include either head computed tomography (CT) or brain magnetic resonance imaging (MRI). Consultation with neurology and admission rates also vary widely. 20 Currently, there is no specific acute intervention for patients with TIA. The goal of evaluating a patient with TIA is to reduce the potential for future strokes. 1 Whereas antiplatelet agents are used as first-line therapy for secondary prevention, a workup should also include an evaluation that may lead to other secondary prevention treatments. This includes identification of high-risk conditions that have effective therapeutic interventions such as severe carotid stenosis or atrial fibrillation.
This clinical policy will address 4 issues related to emergency physicians based on feedback from the American College of Emergency Physicians (ACEP) membership. The first question will look at clinical decision rules to evaluate whether a patient can be safely discharged home after a suspected TIA. Emergency physicians identified this as a critical issue because hospitals may not have the capacity to admit every TIA patient, and outpatient workups, especially to a specialty TIA clinic, have been shown to be a cost-effective alternative to hospital admission for certain subsets of patients. 21, 22 The second clinical question tackles the issue of emergent imaging in the ED. Although imaging has been recommended for TIA, 1 when TIA symptoms have completely resolved, it is unclear whether imaging can be safely deferred and obtained later on an inpatient basis or during outpatient follow-up.
The third question evaluates the accuracy of carotid ultrasonography compared with CT angiography (CTA) and magnetic resonance angiography (MRA) in the evaluation of severe carotid stenosis. This is important for emergency physicians because not all imaging modalities may be readily available in their ED.
Finally, challenges exist in obtaining timely evaluation for high-risk causes of TIA. The fourth question evaluates the safety of an expedited ED-based pathway for the evaluation of TIA.
METHODOLOGY
This clinical policy was created after careful review and critical analysis of the medical literature and was based on a systematic review of the literature. Searches of MEDLINE, MEDLINE InProcess, Cochrane, and SCOPUS were performed. All searches were limited to English-language sources, adults, and human studies. Specific key words/ phrases, years used in the searches, dates of searches, and study selection are identified under each critical question. In addition, relevant articles from the bibliographies of included studies and more recent articles identified by committee members and reviewers were included.
This policy is a product of the ACEP clinical policy development process, including expert review, and is based on the existing literature; when literature was not available, consensus of emergency physicians was used. Expert review comments were received from emergency physicians, neurologists, members of the AHA/ASA, and ACEP's Medical Legal Committee. Comments were received during a 60-day open comment period, with notices of the comment period sent in an e-mail to ACEP members, published in EM Today, and posted on the ACEP Web site. The responses were used to further refine and enhance this policy; however, the responses do not imply endorsement of this clinical policy. Clinical policies are scheduled for revision every 3 years; however, interim reviews are conducted when technology, methodology, or the practice environment changes significantly. ACEP was the funding source for this clinical policy.
Assessment of Classes of Evidence
All articles used in the formulation of this clinical policy were graded by at least 2 methodologists and assigned a Class of Evidence. Each article was assigned a design class with design 1 representing the strongest study design and subsequent design classes (ie, design 2, design 3) representing respectively weaker study designs for therapeutic, diagnostic, or prognostic clinical reports, or meta-analyses (Appendix A). Articles were then graded on dimensions related to the study's methodological features, such as randomization processes, blinding, allocation concealment, methods of data collection, outcome measures and their assessment, selection and misclassification biases, sample size, and generalizability. Using a predetermined process related to the study's design, methodological quality, and applicability to the critical question, articles received a final Class of Evidence grade (ie, Class I, Class II, Class III, or Class X) (Appendix B). Articles identified with fatal flaws or that were ultimately not applicable to the critical question received a Class of Evidence grade "X" and were not used in formulating recommendations for this policy. Grading was done with respect to the specific critical questions; thus, the level of evidence for any one study may vary according to the question for which it is being considered. As such, it was possible for a single article to receive different Classes of Evidence as different critical questions were answered from the same study. Question-specific Classes of Evidence grading may be found in the Evidentiary Table (available online at www.annemergmed. com).
Translation of Classes of Evidence to Recommendation Levels
Strength of recommendations regarding each critical question were made by subcommittee members using results from strength of evidence grading, expert opinion, and consensus among subcommittee members according to the following guidelines:
Level A recommendations. Generally accepted principles for patient care that reflect a high degree of clinical certainty (eg, based on evidence from 1 or more Class of Evidence I or multiple Class of Evidence II studies).
Level B recommendations. Recommendations for patient care that may identify a particular strategy or range of strategies that reflect moderate clinical certainty (eg, based on evidence from 1 or more Class of Evidence II studies or strong consensus of Class of Evidence III studies).
Level C recommendations. Recommendations for patient care that are based on evidence from Class of Evidence III studies or, in the absence of any adequate published literature, based on expert consensus. In instances where consensus recommendations are made, "consensus" is placed in parentheses at the end of the recommendation.
There are certain circumstances in which the recommendations stemming from a body of evidence should not be rated as highly as the individual studies on which they are based. Factors such as heterogeneity of results, uncertainty about effect magnitude and consequences, and publication bias, among others, might lead to such a downgrading of recommendations.
When possible, clinically oriented statistics (eg, likelihood ratios [LRs] , number needed to treat) are presented to help the reader better understand how the results may be applied to the individual patient. For a definition of these statistical concepts, see Appendix C.
This policy is not intended to be a complete manual on the evaluation and management of adults with suspected TIA but rather a focused examination of critical issues that have particular relevance to the current practice of emergency medicine.
It is the goal of the Clinical Policies Committee to provide an evidence-based recommendation when the medical literature provides enough quality information to answer a critical question. When the medical literature does not contain adequate empirical data to answer a critical question, the members of the Clinical Policies Committee believe that it is equally important to alert emergency physicians to this fact.
This clinical policy is not intended to represent a legal standard of care for emergency physicians. Recommendations offered in this policy are not intended to represent the only diagnostic or management options available to the emergency physician. ACEP recognizes the importance of the individual physician's judgment and patient preferences. This guideline defines for the physician those strategies for which medical literature exists to provide support for answers to the critical questions addressed in this policy.
Scope of Application. This guideline is intended for physicians working in EDs.
Inclusion Criteria. This guideline applies to adult patients aged 18 years and older presenting to the ED with a suspected TIA who have had resolution of symptoms.
Exclusion Criteria. This guideline is not intended to be used for pediatric patients.
For potential benefits and harms of implementing the recommendations, see Appendix D. Study Selection: Three hundred seventy-eight articles were identified in the search. Seventy-two articles were selected from the search results for further review, with 34 studies included for this critical question.
CRITICAL QUESTIONS
This critical question focuses on pretest probability assessment for short-term stroke risk after evaluation for suspected TIA. Estimation of pretest probability is imperative for the accurate interpretation of posttest probability for any diagnostic or prognostic test. Pretest probability for short-term stroke risk can be estimated in 3 general ways: objective criteria (eg, risk stratification instruments), clinician gestalt, or extrapolation from studies reporting post-TIA stroke rates in similar populations.
A subset of ED patients with TIA are at increased risk for strokes in the days and weeks after the index ED presentation. Because access to advanced diagnostics such as echocardiography, carotid imaging, and telemetry may be limited, the challenge is timely recognition of TIA patients who are most likely to progress to stroke within a shorter timeframe and who could benefit from interventions such as anticoagulation or carotid endarterectomy to reduce this stroke risk. 23 The 2009 AHA/ASA TIA guidelines recommend hospital admission for (1) individuals with ABCD2 score greater than or equal to 3, (2) those with ABCD2 score 0 to 2 if "uncertain that diagnostic workup can be completed within 2 days as an outpatient," or (3) when "other evidence indicates the patient's event was caused by focal ischemia."
3 Therefore, the most compelling rationale to incorporate TIA risk stratification instruments into clinical practice is evidence that when used alone without additional history, physical examination, imaging, or laboratory testing, they may differentiate low-risk patients with TIA for whom advanced workup and specialty consultations can be deferred from those subsets who are at increased short-term risk (ie, 2 to 7 days) for stroke.
Six TIA risk stratification instruments have been evaluated in studies that met the inclusion criteria: ABCD, outcomes, leading to a lack of precision (ie, wide confidence intervals [CIs]) for most point estimates. Most of the prospective studies do not specify whether clinicians were blinded to the risk stratification results or had incorporated these risk estimates into clinical management decisions. In addition, these studies had an unacceptably high rate of lost to follow-up.
The most frequently studied risk stratification instrument is the ABCD2 score (Appendix E).
6-13,17,26,27,31-47 The ABCD2 score was derived and validated using retrospective data from the California and Oxfordshire groups in a Class II 11 study. Using 1,916 patients with suspected TIA in the derivation group and 2,892 in the validation group, they noted a 3.9% and 7.5% frequency for stroke at 2 and 7 days, respectively. Using a threshold of less than 4, the ABCD2 score identified 33.8% of patients as "low risk," with strokes occurring in 1% and 1.2% of these low-risk patients at 2 and 7 days, respectively. Since the derivation of the ABCD2 score, 6 Although the discriminatory accuracy of ABCD2 to distinguish patients with suspected TIA at low or high shortterm risk for stroke is less convincing than the original derivation and validation set, 11 many of these subsequent studies did not report LRs or sufficient detail to compute LRs at any timeframe after the TIA.
12,25,27,35,38,41-43 The ABCD2 negative LRs for 2-to 7-day stroke risk among the studies that did report these data vary widely, from 0 to 1.1, with significant imprecision and wide CIs. [7] [8] [9] 11, 13, 17, 32, 34, 40, 44 The 7 Class II 11,34,40,42,44,45,47 studies of the ABCD2 score are limited by uncertain blinding of outcome assessors to the ABCD2 score. This could have potentially skewed any observed prognostic accuracy because of aggressive TIA management based on the observed ABCD2 score. These interventions could have prevented short-term strokes that the ABCD2 score would have predicted if preventive interventions guided by the ABCD2 score had not been implemented. Inconsistent reporting of short-term (2-or 7-day) stroke rates and high rates of lost to follow-up were also common limitations. In addition, the feasibility of ED clinicians scoring the ABCD2 in real time was rarely assessed; instead, research teams usually calculated the score either retrospectively or prospectively. In a Class II study, Wasserman et al 47 prospectively evaluated 1,093 consecutive adults with suspected TIA at 2 Canadian tertiary care EDs, including 1.6% admitted from the ED. Strokes were observed in 3.2% of patients at 90 days, which was approximately one-third the rate predicted by the ABCD2 score; stroke outcomes in this study were determined by a neurologist who was not blinded to the ABCD2 score. The ABCD2 negative LR for 90-day stroke was 0.29 (95% CI 0.08 to 0.81).
In a Class II study, Cancelli et al 34 prospectively evaluated 161 TIA patients in 1 Italian stroke referral center, noting an 11.5% 90-day stroke rate. An ABCD2 score less than 4 was associated with a 0% stroke rate at 2, 7, 30, and 90 days, but only 4 strokes were observed in 2 days, creating an unacceptably wide CI (negative LR 0; 95% CI 0 to 1.9). Stead et al 44 reported 7-day stroke risk in a single-center retrospective study of 637 adult patients with suspected TIA. The 7-day stroke risk was 1%, and strokes occurred in 1.1% of individuals with an ABCD2 score less than 4, representing a negative LR of 1.1 (95% CI 0.2 to 2.6). A Class II study by Ozpolat et al 40 reported on 64 patients with TIA in a Turkish ED using convenience sampling; 12.5% had stroke within 3 days of the TIA, yet none of these patients had an ABCD2 score less than 4, thus representing a negative LR of zero. In a Class II study, Wardlaw et al 45 reported a systematic review of 26 studies including 12,586 patients, assessing 7-day stroke risk with ABCD2 less than 4 (34%) versus greater than or equal to 4 (55%), but they combined heterogeneous prospective and retrospective studies without stratifying analysis by populations, study design, or quality. They also did not report LRs. Finally, a Class II study by Perry et al 42 reported a multicenter prospective study comparing the ABCD2 score with the Canadian TIA Score for predicting the 7-day risk for strokes. Although the Canadian TIA Score was shown to be superior to the ABCD2 score, the Canadian TIA Score has not been validated.
Multiple Class III 8,9,12,13,24,25,27,30,38,48 studies evaluated other risk stratification instruments. Similar to the ABCD2, none of these instruments demonstrated sufficient diagnostic accuracy to identify TIA patients at lower short-term risk for stroke, with negative LRs ranging from 0 to 0.55 and CIs that generally crossed 1. The negative LRs and imprecision of each score are not sufficiently accurate or precise to confidently risk stratify TIA patients for short-term risk of stroke. Several of the modified instruments such as ABCD-I, ABCD2-I, and ABCD3-I incorporate concurrent ED MRI, which is beyond the scope of this question. 8, 12, 27, 29, 36 The ABCD has been evaluated in 3 Class II 11, 28, 29 studies and 7 Class III 9,13,24-27,30 studies with negative LRs for ABCD less than 4 for 7-day stroke risk, which extended from an LR of 0 (95% CI 0 to 0. 55) 28 to 0.12 (95% CI 0.01 to 0. 65) 30 to 0.39 (95% CI 0.13 to 0.99). 9 ABCD scores were not more accurate at determining 2-day strokes, with negative LRs of 0.30 (95% CI 0.02 to 1.4). 13 The ABCD3 has been evaluated in 3 As illustrated in Appendix D, the ABCD2 score, which has both the largest number of studies and the highest Class of Evidence, does not reduce the posttest probability of 2-or 7-day stroke risk sufficiently to identify patients at very low short-term risk for stroke. Multiple other scores including the ABCD, ABCD3, California, Canadian TIA Score, and Essen Stroke Risk, have been evaluated less extensively and also appear to lack sufficient prognostic accuracy to independently identify patients at very low short-term risk for stroke.
To summarize, the literature supports 2 key findings: Study Selection: Four hundred forty-one articles were identified in the search. Eighty-five articles were selected from the search results for further review, with 13 studies included for this critical question.
When an emergency physician provides care to a patient with a suspected TIA, decisions about immediate imaging versus delayed imaging must be made. The primary goal of imaging is to identify serious TIA mimics (eg, intracranial hemorrhage, mass lesion). Another goal is to potentially identify patients at high short-term risk for stroke, commonly defined as occurring within 2 or 7 days after the initial TIA event. However, each imaging modality has different performance characteristics, as well as associated length of stay and cost. The majority of the literature applicable to this clinical question deals with head CT, brain MRI, or cervical vessel imaging. Therefore, the discussion will center on these 3 options.
The majority of studies used in this clinical policy used a time-based definition of TIA (ie, resolution of neurologic deficit within 24 hours). However, immediate imaging may reveal acute ischemic lesions despite resolution of neurologic deficits, changing the diagnosis to stroke. Because both TIA and minor stroke have similar short-term ischemic stroke risk, management considerations may be similar regardless of whether tissue infarction is detected on brain imaging. 1, 51 Based on the study selection criteria, 4 
Head CT
In a multicenter Class II study from Germany, 52 1,533 patients with suspected TIA underwent head CT as part of the initial diagnostic evaluation. An acute cerebrovascular accident was detected on initial head CT in 47 patients (3.1%) even though every patient received a clinical diagnosis of TIA because of resolution of neurologic deficits within 24 hours. All 1,533 patients were admitted to the hospital, with a mean admission duration of 6 days. While in the hospital, 17 patients (1.1%) experienced an ischemic stroke. No patients with a new infarct on initial head CT experienced another ischemic stroke while in the hospital, and the presence of a new infarct on initial head CT was not associated with a new short-term stroke.
Another multicenter Class II study 29 examined 274 patients presenting to EDs in Italy with suspected TIA. All patients underwent head CT in the ED. The authors attempted to determine the marginal benefit of adding head CT findings to the ABCD score, reformulated as the ABCD-I score, in predicting the short-term risk for stroke. In this cohort, 7 patients (2.6%) experienced an ischemic stroke within 2 days, 10 (3.6%) within 7 days, and 15 (5.5%) within 30 days of initial presentation. The ABCD-I score essentially had the same performance characteristics as the ABCD score in predicting 7-day stroke (odds ratio [OR] for every point was 2.7 versus 2.6). The presence of "leukoaraiosis and/or old/new ischemia lesions" on head CT was not an independent predictor of 7-day stroke.
One Class III study 55 also did not support the ability of head CT to predict the rate of subsequent stroke. There was no difference in the frequency of 90-day stroke between patients who received a head CT and those who did not (10.9% for both groups). However, among patients having an initial head CT, an alternative diagnosis was identified in 4 of 322 (1.2%; 95% CI 0.0% to 3.1%), 1 patient with a chronic subdural and 3 patients with mass lesions.
In contrast to the other studies that did not identify a prognostic value with immediate head CT, a multicenter Class II study that enrolled 2,028 patients from 8 Canadian EDs with TIA or nondisabling stroke supported the ability of early head CT to predict short-term stroke. 53 All patients experienced resolution of neurologic deficit within 24 hours of symptom onset, and each patient received a head CT within 24 hours of presentation. A subsequent stroke within 2 days was identified in 31 subjects (1.5%). Using a logistic regression model, the investigators reported an association with 2-day stroke for acuteþchronic ischemia (OR 10.32), acute ischemiaþmicroangiopathy (OR 8.44), and acuteþchronic ischemiaþmicroangiopathy (OR 22.69) . Although these findings were in contrast to those of the other articles reviewed, this study allowed initial head CT up to 24 hours after presentation and may not reflect the use of immediate CT in the ED.
Brain MRI and/or Cervical Vessel Imaging
One Class II 54 study and 4 Class III 8, 33 ,39,56 studies examined a combination of brain MRI and vascular imaging in the evaluation of suspected TIA. Although some studies incorporated intracranial in addition to cervical vascular imaging, there is insufficient evidence in determining the value of identifying intracranial vascular lesions given the limited number of studies examining this modality, the difficulty in segregating the analysis from the identification of cervical vascular lesions, and the lack of potential beneficial interventions if an intracranial vascular lesion is identified. In a single-center Class II 54 study, 162 patients with TIA underwent multimodal MRI and contrast-enhanced MRA of the head and neck. All 162 patients completed 90 days' follow-up; 23 patients (14.2%) experienced subsequent TIA (n¼16) or stroke (n¼7). Subsequent ischemic events occurred within 3 days in 13 patients (56.5%) and within 7 days of the initial TIA in 18 patients (78.3%). Although the majority of ischemic events occurred within 7 days of the initial TIA, analysis was directed at the primary endpoint of 90-day events, finding that 23 of 23 patients (100%) with a 90-day ischemic event had an initial imaging abnormality versus 97 of 139 patients (69.8%) without an event. In a multivariable analysis, symptomatic MRA abnormality, defined as intracranial or extracranial stenosis greater than 50% in a territory appropriate to the patient's symptoms, was found to be the only independent predictor of a 90-day ischemic event (OR 12.7).
In a Class III study, Calvet et al 33 examined 343 patients with suspected TIA who received a brain MRI and an intracranial MRA. In addition, all patients underwent carotid Doppler ultrasonography, with 307 of 343 (90%) also receiving cervical contrast-enhanced MRA. Patients without contrast-enhanced MRA had either a normal carotid Doppler result or contraindications to MRA with contrast. Ischemic stroke was observed in 4 of 343 patients (1.2%) within 48 hours and 5 of 343 (1.5%) at 7 days. Positive MRI result with DWI was a univariate predictor of Clinical Policy 7-day risk for stroke, and all patients with stroke within 7 days had a positive DWI result and ABCD2 score of 4 or greater (5 of 90; 5.4%). In a multivariable analysis of 90-day stroke risk that included the ABCD2 score, positive DWI result (hazard ratio 8.7) and large artery atherosclerosis (hazard ratio 3.4) were imaging predictors. Unfortunately, a multivariable model for 7-day stroke risk was not reported.
Another Class III 39 study reviewed protocol-guided imaging in 224 patients presenting to a single center with suspected TIA. All patients received a noncontrast head CT in the ED. Those with ABCD2 score of 0 to 3 were eligible to be discharged directly from the ED to a TIA clinic visit in 1 to 2 business days without immediate imaging. An MRI and MRA (cervical and intracranial) were obtained before the clinic visit. Patients with an ABCD2 score of 4 to 5 underwent cervical and intracranial vessel imaging (typically with CTA) in the ED. Those with ABCD2 score greater than 5 were hospitalized. Six of 14 hospitalized patients found to have symptomatic vessel occlusion or high-grade stenosis underwent vascular intervention, although the time to intervention was not well described. One of 157 patients (0.6%) sent to the TIA clinic experienced ischemic stroke. Among all 224 patients, 2 patients (0.9%) experienced a stroke, which was less than the 4% expected stroke rate.
Chatzikonstantinou et al 8 conducted a Class III study examining 235 patients with suspected TIA who underwent early DWI and carotid Doppler ultrasonography. Seventeen of 235 patients (7.2%) experienced ischemic stroke during hospitalization (mean duration 7.4 days). The ABCD3-I score, a risk tool that incorporates positive DWI findings and relevant carotid stenosis, was found to be a predictor of inhospital stroke.
A Class III 56 study followed 116 patients with suspected TIA to evaluate for subsequent stroke within 30 days. Patients underwent both DWI and cervical vessel imaging. Two strokes (1.8%) occurred during the 30-day follow-up period and both were within the first 48 hours of hospitalization. Subsequent risk for stroke was higher among DWI-positive (6.3%) compared with DWInegative (1.2%) patients. Twenty of 110 (17.2%) cervical vessel imaging studies were positive and 6 of these patients underwent carotid intervention.
Three Class III studies investigated the use of DWI.
6,31,57 A multicenter study of 944 patients with suspected TIA found that the lack of a lesion on DWI was associated with a low 90-day risk for stroke. 31 The investigators suggested that a combination of ABCD2 score and early DWI may be an effective strategy for predicting the 90-day risk for stroke. Another Class III study 6 reported that early DWI was beneficial in predicting 7-day stroke. Twenty-three of 477 patients (4.8%) experienced subsequent stroke within 7 days of suspected TIA and, based on a logistic regression model, the identification of an acute ischemic lesion on DWI was an independent predictor of 7-day stroke (OR 10.1). A Class III systematic review by Oostema et al 57 included 6 studies examining subsequent stroke within 2 and 7 days after TIA in patients undergoing early DWI. Two-day stroke occurred in 0% to 2.9% of DWI-negative patients and 0% to 14.3% of DWIpositive patients. Seven-day stroke occurred in 0% to 2.9% of DWI-negative patients and 0% to 23.8% of DWIpositive patients.
One Class III study by Daubail et al 58 examined the determination of TIA mechanism as a predictor of early stroke risk. All patients underwent brain imaging and evaluation of the cervical vasculature, with most receiving a head CT and CTA. Ten of 312 patients (3.2%) experienced a recurrent ischemic event, 5 with ischemic strokes and 5 with TIA. Large artery atherosclerosis, defined as stenosis of more than 50% of a cervical or intracranial artery, that could explain the neurologic symptoms of the TIA was identified in 33 of 312 patients (10.6%). Of the 33 patients with a large artery atherosclerosis TIA, 4 (12.1%) experienced a recurrent ischemic event within 48 hours. Large artery atherosclerosis as the etiology of the TIA was a strong independent predictor (OR 12) for a recurrent ischemic event within 2 days.
To summarize, the evidence supports 3 key findings:
1. Although there is limited research quantifying the mimics identified on initial imaging in patients presenting with suspected TIA, it is likely that initial noncontrast brain imaging in the ED will identify some patients with serious alternative diagnoses. However, there is no evidence evaluating the safety of delaying neuroimaging in the ED. 2. Initial noncontrast head CT findings do not reliably predict early stroke in patients presenting with suspected TIA. 3. Both DWI and cervical vascular imaging predict short-term risk for stroke in patients presenting with suspected TIA. Unfortunately, the literature surrounding this topic focuses on the diagnostic and prognostic values of imaging but does not routinely examine whether early recognition of abnormal findings translates into improved outcomes. It is unclear whether immediate diagnosis of a serious TIA mimic on initial head CT in the ED rather than obtaining urgent outpatient imaging results in improved patientcentered outcomes. Furthermore, although identifying high-risk patients may allow earlier intervention and more intensive monitoring, meaningful benefits to the TIA population have not been demonstrated. Given the lack of clear evidence that supports improved patient-centered outcomes, consideration of local systems of care and shared decisionmaking that incorporates patient preferences are important in choosing the timing of early imaging for suspected TIA.
Future Research
Much of the literature examining the utility of initial imaging does not examine testing that is practical and available in most EDs and does not use identification of TIA mimics or prediction of early (ie, 2-or 7-day) stroke as the primary outcome. Future research should focus on:
Quantifying the ability of noncontrast head CT and noncontrast brain MRI to detect clinically important TIA mimics in patients presenting with suspected TIA who have had resolution of symptoms at ED presentation, because the majority of TIA research excludes these patients. The safety of delaying neuroimaging from the initial ED workup, including discharge from the ED for an outpatient workup.
Integration of a risk score and imaging strategy to identify TIA patients at high short-term risk for stroke to improve risk stratification for ED patients with suspected TIA. Identifying acute interventions for patients with TIA that improve functional outcomes, quality of life, and other patient-centered outcomes.
3. In adult patients with suspected TIA, is carotid ultrasonography as accurate as neck CTA or MRA in identifying severe carotid stenosis?
Patient Management Recommendations Level A recommendations. None specified. Level B recommendations. None specified. Level C recommendations. In adult patients with suspected TIA, carotid ultrasonography may be used to exclude severe carotid stenosis because it has accuracy similar to that of MRA or CTA.
Key words/phrases for literature searches: transient ischemic attack, TIA, carotid stenosis, ultrasound, angiogram, CT, MRI, neuroimaging, emergency treatment, decisionmaking, delayed diagnosis, ultrasonography, carotid arteries, angiography, neck, and variations and combinations of the key words/phrases. Searches included January 1, 2000 to search date of March 18, 2015.
Study Selection: Three hundred ninety-eight articles were identified in the search. Thirty-four articles were selected from the search results for further review, with 8 studies included for this critical question.
Carotid endarterectomy has been shown to be beneficial within 2 weeks from a TIA or stroke for severe carotid stenosis, which is defined as stenosis between 70% and 99%, with a number needed to treat of 6 to prevent future stroke or death. 59, 60 Historically, catheter-based angiography was the gold criterion for evaluating carotid stenosis. However, noninvasive imaging methods (ie, carotid ultrasonography, CTA, and MRA) have since replaced catheter-based angiography as a first-line test. This question focused on the use of carotid ultrasonography for the detection of severe carotid stenosis because ultrasonography has the benefits of being more available in some ED settings, avoids the need for intravenous contrast, and is typically less expensive than CTA or MRA. Although each institution has its own protocols for carotid ultrasonography, the literature review did not focus on the specifics of these protocols, such as ideal peak velocity, types of Doppler, and the use of contrast, nor did it focus on point-of-care ultrasonography.
A Class III study by D'Onofrio et al 61 prospectively evaluated 32 patients who either had carotid Doppler ultrasonography (DUS) or contrast-enhanced MRA and compared it to either digital subtraction angiography (DSA) or endarterectomy. Both had strong correlation in identifying stenosis, with both identifying 100% of surgical stenosis (defined as carotid stenosis of 60% to 99%). Doppler ultrasonography had a negative LR of 0.07 (95% CI 0.01 to 0.47) and a positive LR of 3.2 (95% CI 1.6 to 6.2), and MRA had a negative LR of 0.07 (95% CI 0.01 to 0.47) and a positive LR of 3.2 (95% CI 1.6 to 6.2). In another Class III 62 study, 313 patients with TIA or minor stroke had DUS. When compared with DSA, using a peak systolic velocity of 230 cm/s, DUS had a sensitivity of 95% (95% CI 92% to 99%), specificity of 51% (95% CI 42% to 61%), negative LR of 0.09 (95% CI 0.04 to 0.20), and positive LR of 2.0 (95% CI 1.6 to 2.4) for carotid stenosis of 70% to 99%.
In a Class III 63 study, 350 patients with TIA or nondisabling stroke were prospectively evaluated for carotid stenosis. DUS demonstrated a sensitivity of 88% (95% CI 82% to 93%), specificity of 76% (95% CI 69% to 82%), negative LR of 0.17 (95% CI 0.11 to 0.26), and positive LR of 3.6 (95% CI 2.7 to 4.7) compared with DSA for severe stenosis (70% to 99%). MRA had a sensitivity of 92.2% (95% CI 86.2% to 96.2%), specificity of 75.7% (95% CI 68.6% to 82.5%), negative LR of 0.10 (95% CI 0.06 to 0.19), and positive LR of 3.8 (95% CI 2.9 to 5.0) Clinical Policy for severe stenosis. In another Class III 64 study, a secondary analysis was performed on 56 patients with suspected carotid stenosis of greater than 50%. Contrast-enhanced MRA, DUS, and DSA were performed within 15 days of enrollment. Contrast-enhanced MRA was read by 3 independent readers, and sensitivity and specificity were scored separately for each reader. Compared with DSA, DUS had a sensitivity of 83% (95% CI 68% to 93%), specificity of 86% (95% CI 76% to 93%), negative LR of 0.19 (95% CI 0.09 to 0.40), and positive LR of 6.0 (95% CI 3.3 to 10.9) for stenosis greater than or equal to 70%, whereas contrast-enhanced MRA had a sensitivity of 95% (95% CI 81% to 99%), specificity ranging from 77% to 85% among the 3 readers, a negative LR of 0.07 (95% CI 0.02 to 0.27), and positive LR of 4.1 (95% CI 2.6 to 6.2). Figure 1 shows the LR from the various studies.
Four Class III meta-analyses were identified. [65] [66] [67] [68] All had significant heterogeneity. Blakely et al 65 included 70 articles from 1977 to 1993 assessing direct and indirect comparisons of ultrasonography and MRA with carotid angiography. Carotid DUS, carotid duplex ultrasonography, and MRA had sensitivities between 82% and 86% and specificities of 98% for detecting 100% occlusion. When predicting greater than 70% carotid stenosis, these 3 diagnostic imaging tests and supraorbital Doppler ultrasonography had similar sensitivities ranging from 83% to 86%.
A Class III meta-analysis by Nederkoorn et al 66 included 63 articles from 1994 to 2001 comparing DUS and MRA with DSA. For the diagnosis of 70% to 99% stenosis versus less than 70% stenosis, MRA was found to be more sensitive than DUS, with a sensitivity of 95% (95% CI 92% to 97%) versus 86% (95% CI 84% to 89%), respectively, but similar specificity of 90% (95% CI 86% to 93%) versus 87% (95% CI 84% to 90%), respectively. Another Class III meta-analysis by Jahromi et al 67 included 47 articles from 1996 to 2003 comparing DUS with carotid angiography. Using a threshold peak systolic velocity greater than or equal to 200 cm/s, DUS had a sensitivity of 90% (95% CI 84% to 94%) and a specificity of 94% (95% CI 88% to 97%) for the diagnosis of stenosis of greater than or equal to 70%. However, substantial heterogeneity was identified based on differences in patient populations, study design, equipment, techniques, and training of the sonographer.
Finally, a Class III meta-analysis by Wardlaw et al 68 evaluated 41 studies comparing DUS, CTA, and contrastenhanced MRA. For carotid stenosis between 70% and 99%, contrast-enhanced MRA had a sensitivity of 94% (95% CI 88% to 97%), specificity of 93% (95% CI 89% to 96%), negative LR of 0.06, and positive LR of 13.4. Doppler ultrasonography had a sensitivity of 89% (95% CI 85% to 92%), specificity of 84% (95% CI 77% to 89%), negative LR of 0.13, and positive LR of 5.6. CTA had a lower sensitivity of 77% (95% CI 68% to 84%), specificity of 95% (95% CI 91% to 97%), negative LR of 0.24, and positive LR of 15.4. To summarize, the evidence supports 3 key findings: 1) Although ultrasonography appears to be slightly less sensitive than MRA for detecting severe carotid stenosis, the diagnostic test performs well enough clinically to be considered useful in ruling out clinically significant carotid stenosis. 2) The specificity of both MRA and DUS for detecting severe carotid stenosis appears to be similar. 3) There were no studies included directly comparing CTA and DUS. Future research The majority of the literature on noninvasive imaging used older technology, often comparing a single modality with a reference standard. The studies evaluating DUS used different protocols in determining severe carotid stenosis. Future research should focus on:
Comparative effectiveness studies that directly compare noninvasive forms of imaging using standardized protocols that report patient-centered outcomes. Determining the accuracy of emergency physician performed point-of-care carotid ultrasonography for the identification of severe carotid stenosis.
4. In adult patients with suspected TIA, can a rapid EDbased diagnostic protocol safely identify patients at short-term risk for stroke?
Patient Management Recommendations Level A recommendations. None specified. Level B recommendations. In adult patients with suspected TIA without high-risk conditions,* a rapid EDbased diagnostic protocol may be used to evaluate patients at short-term risk for stroke.
Level C recommendations. None specified. *High-risk conditions include abnormal initial head CT result (if obtained), suspected embolic source (presence of atrial fibrillation, cardiomyopathy, or valvulopathy), known carotid stenosis, previous large stroke, and crescendo TIA.
Key words/phrases for literature searches: transient ischemic attack, TIA, stroke, risk, diagnosis, emergency, critical pathways, practice guidelines, and variations and combinations of the key words/phrases. Searches included January 1, 2000 to search date of March 18, 2015.
Study Selection: Three hundred forty-nine articles were identified in the search. Sixty articles were selected from the search results for further review, with 8 studies included for this critical question.
Use of a rapid ED-based diagnostic protocol can stratify patients with high short-term risk for stroke. Data from multiple Class II and Class III studies described below demonstrate the safety and feasibility of this approach versus inpatient management in appropriately selected patients. Current evidence also suggests shorter hospital length of stay, decreased hospital cost, and higher compliance with evidence-based guideline recommendations 3 when a properly designed and executed ED-based diagnostic protocol (eg, ED observation unit) is used compared with standard inpatient admission. 56, 69 An example of a model for an ED-based diagnostic protocol is shown in Figure 2 . Based on study selection criteria, The TIA clinic studies used referral to further diagnostic testing (eg, neuroimaging, echocardiogram) that occurred during the interval between point of first presentation and clinic follow-up. These clinic trials were included because the workflow provided could be replicated in an ED-based diagnostic protocol.
A Class II trial by Ross et al 69 prospectively randomized 149 ED TIA patients to an accelerated diagnostic protocol in an ED observation unit versus standard hospital admission. Notable exclusions were an abnormal initial head CT result, known possible embolic source (history of atrial fibrillation, cardiomyopathy, or valvulopathy), known carotid stenosis, previous large stroke, and crescendo TIAs. Their diagnostic protocol consisted of carotid imaging (DUS or MRA), echocardiography, serial clinical evaluation, and cardiac monitoring for at least 12 hours. Patients with recurrent neurologic symptoms, significant carotid stenosis, or evidence of thromboembolic source were admitted. They found that an accelerated diagnostic protocol was associated with a shorter median length of stay (25.6 hours; 95% CI 21.9 to 28.7 versus 61.2 hours; 95% CI 41.6 to 92.2) and lower 90-day costs ($890, 95% CI $768 to $1,510 versus $1,547, 95% CI $1,091 to $2,473), and no increase in adverse outcomes versus mandatory inpatient admission.
A Class II study by Lavallée et al 21 found similar results. They evaluated the value of a 24/7 TIA specialty clinic in which referred patients received comprehensive testing and examination by a vascular neurologist. This study examined 1,085 patients and compared 90-day stroke incidence versus stroke risk predicted by ABCD2 score. The authors reported a 1.2% (95% CI 0.7% to 2.1%) risk for stroke versus an expected 6% risk for stroke based on ABCD2 score. Seventy-four percent of patients were evaluated and discharged on the same day of presentation. The major weakness of this trial was the lack of a true control group.
In a Class II study, Stead et al 70 evaluated the feasibility of TIA evaluation in an ED observation unit. Similar to that used by Ross et al, 69 protocolized care was used to evaluate patients with TIA who were asymptomatic and had a negative head CT result. Of the 418 patients enrolled, only 127 (30.4%) were discharged directly after evaluation from the ED observation unit. A major limitation was the lack of Clinical Policy a control group; outcomes were compared with the expected rates of stroke at 2 and 7 days. Their conclusion was that their protocol was feasible and safe.
In a Class III study, Oostema et al 56 examined the use of DWI in an accelerated diagnostic protocol conducted in an ED observation unit. Exclusion criteria similar to those used by Ross et al 69 were used. Head CT was not conducted during the initial ED management. All patients in the accelerated diagnostic protocol received neuroimaging, with 94% receiving DWI. A greater percentage of patients in the accelerated diagnostic protocol received cervical vessel imaging compared with those triaged to inpatient management (97% versus 83%). In approximately 13.8% of ED observation unit patients, DWI was positive for acute infarction. This was the only positive finding in 6.9% of patients. The authors estimated a number needed to test of 15 to identify high-risk findings not present on other evaluations. Patients who were DWI positive had a higher 30-day risk for stroke than those without DWI lesions (6.3% versus 1.2%). Oostema et al 56 showed a length of stay similar to that in the study by Ross et al 69 (19 hours), with 59.5% of patients discharged from These studies differed in their triage criteria, ED evaluation and management, outpatient workup, and time to follow-up. Each study is limited by lack of true control, with some using before-and-after design and others using comparison with predicted stroke risk at outcome.
In a Class II study, Olivot et al 39 stratified patients according to risk factors to different ED workups. Patients at low risk (ABCD2 score of 0 to 3) were eligible for direct discharge from the ED, with referral to an outpatient TIA clinic. Patients at moderate risk (ABCD2 score 4 to 5) had cervical and intracranial vessel imaging while in the ED, and if the results were positive (defined as having >50% narrowing), the patients were admitted. Patients with an ABCD2 score greater than 5 were admitted to the hospital. Patients referred to the TIA clinic were referred for neurovascular imaging and began receiving antiplatelet agents. Of the 224 patients enrolled, 70% were discharged from the ED directly and 61% of patients had vascular imaging performed while in the ED. The median time from ED visit to TIA clinic was 3 days (interquartile range 2 to 5). Of patients discharged from the ED, 9% had acute DWI lesions on outpatient MRI. The observed rate for stroke at 7 and 90 days was lower than expected based on the ABCD2 score.
Two Class III 71,72 studies and 1 Class II 47 study used a model in which ED patients were referred to an outpatient TIA clinic for further workup. Risk stratification and exclusion criteria differed among the studies. Follow-up to the TIA clinic from the ED was also variable, ranging from 2 to greater than 14 days. A lower rate for stroke was found compared with the rate for stroke predicted based on stroke scores. These studies also found a decreased cost associated with referral to the TIA clinic compared with inpatient management; however, they were limited by their lack of prospective control groups and sample size. This also required the development, implementation, and maintenance of an outpatient apparatus that could reliably perform an extensive diagnostic evaluation, as well as followup on abnormal test results. Therefore, the results may not be generalizable to centers that do not have similar outpatient resources or where compliance with follow-up is a concern.
To summarize, the evidence supports the 2 following findings:
1) In patients without high-risk conditions, a rapid EDbased diagnostic protocol is equivalent to mandatory admission in terms of patient safety (ie, recurrent cerebrovascular event or stroke). 2) A properly implemented rapid ED-based diagnostic protocol is associated with decreased hospital costs and length of stay compared with inpatient management.
Further research to determine which components are essential for the safest and most efficient ED-based rapid diagnostic protocol with an emphasis on patient-centered outcomes is needed.
Relevant industry relationships: There were no relevant industry relationships disclosed by the subcommittee members for this topic.
Relevant industry relationships are those relationships with companies associated with products or services that significantly impact the specific aspect of disease addressed in the critical question. Appendix C. Likelihood ratios and number needed to treat.*
Giles
MF, Albers GW, Amarenco P, et al. Early stroke risk and ABCD2 score
LR (D) LR (-)
1.0 1.0 Does not change pretest probability 1-5 0.5-1 Minimally changes pretest probability 10 0.1 May be diagnostic if the result is concordant with pretest probability 20 0.05 Usually diagnostic 100 0.01 Almost always diagnostic even in the setting of low or high pretest probability LR, likelihood ratio. *Number needed to treat (NNT): number of patients who need to be treated to achieve 1 additional good outcome; NNT¼1/absolute risk reductionÂ100, where absolute risk reduction is the risk difference between 2 event rates (ie, experimental and control groups).
Appendix D. Potential benefits and harms of implementing the recommendations.
1. In adult patients with suspected TIA, are there clinical decision rules that can identify patients at very low short-term risk for stroke who can be safely discharged from the ED?
Patient Management Recommendations Level A recommendations. None specified. Level B recommendations. In adult patients with suspected TIA, do not rely on current existing risk stratification instruments (eg, ABCD2 score) to identify TIA patients who can be safely discharged from the ED.
Level C recommendations. None specified.
Potential Benefit of Implementing the Recommendations: Clinicians recognize the limitations of using existing risk stratification instruments in suspected TIA patients to identify those at very low short-term risk for stroke.
For example, a 61-year-old right-handed woman is evaluated in the ED 2 hours after a now-resolved 20-minute episode of right arm weakness without associated speech difficulty. Initial workup result is unremarkable in the ED, and the provider contemplates sending the patient home for outpatient follow-up. According to a large cohort study, TIA patients have an estimated 5% risk of having a stroke within 2 days.
11 Given that her ABCD2 score is less than or equal to 4 (negative LR 0.81), 7 her posttest probability is 4%. In this case, the risk is not sufficiently low enough to discharge the patient home (see Figure 3 for calculation).
Potential Harm of Implementing the Recommendations: The harm associated with the implementation of this recommendation is largely unknown, but given the lack of evidence-based guidance, practice variability in the ED management of TIA patients with respect to subsequent test ordering, consultations, and disposition decisions will likely persist.
In adult patients with suspected TIA, what imaging
can be safely delayed from the initial ED workup?
Patient Management Recommendations Level A recommendations. None specified. Level B recommendations. None specified. Level C recommendations.
(1)The safety of delaying neuroimaging from the initial ED workup is unknown. If noncontrast brain MRI is not readily available, it is reasonable for physicians to obtain a noncontrast head CT as part of the initial TIA workup to identify TIA mimics (eg, intracranial hemorrhage, mass lesion). However, noncontrast head CT should not be used to identify patients at high short-term risk for stroke. (2) When feasible, physicians should obtain MRI with DWI to identify patients at high short-term risk for stroke. (3) When feasible, physicians should obtain cervical vascular imaging (eg, carotid ultrasonography, CTA, or MRA) to identify patients at high short-term risk for stroke. Bayesian reasoning uses LRs and pretest odds to estimate posttest odds, using this equation.
Pretest odds×LR=posttest odds
Odds=Probability/(1-probability) Probability=Odds/(odds+1) So using the case above, pretest probability=5% so pretest odds=0.05/(1 to 0.05)=0.053 Pretest odds×LR (-)=posttest odds=0.053×0.81=0.043 Posttest probability=0.043/(0.043+1)=0.04, or 4% Figure 3 . Example: Calculation of posttest probability. cervical vascular imaging may identify patients at high short-term risk for stroke, leading to admission for close clinical monitoring, treatment of high-risk conditions, and possible inhospital interventions for new symptoms.
Potential Harm of Implementing the Recommendations: Additional ED imaging may add to ED cost and length of stay. Contrast-enhanced studies are associated with allergic reaction or anaphylaxis, nephrogenic systemic fibrosis (MRI contrast), and a possible increased risk for renal injury.
The identification of patients at high short-term risk for stroke on immediate imaging has not been demonstrated to lead to interventions that clearly improve patient-centered outcomes (eg, mortality, disability, functional outcomes). Consequently, hospitalization may result in unnecessary increased costs, increased hospital length of stay, and potential nosocomial complications.
Potential Benefit of Implementing the Recommendations: Screening for severe carotid stenosis by ultrasonography has the potential to reduce cost and exposure to radiation and contrast compared with CTA or MRA.
Potential Harm of Implementing the Recommendations: The use of carotid ultrasonography may miss a small percentage of patients with severe carotid stenosis.
Potential Benefit of Implementing the Recommendations: Clinicians can minimize risk of premature discharge from the ED for patients with TIA while potentially decreasing the length of stay and cost versus a protocol that mandates routine hospital admission of TIA patients.
Potential Harm of Implementing the Recommendations: Implementing this recommendation could increase ED length of stay, which may have a negative effect on flow and the care of other ED patients. It may also lead to further testing or interventions that do not ultimately improve patient-centered outcomes. Study included minor strokes; study was a hospital-based 24-h stroke clinic, similar to an ED observation unit; it was not an ED-based protocol, but it could conceivably be conducted in an ED setting; major weakness is lack of true control group; compared actual stroke incidence vs expected stroke incidence predicted by ABCD2 score Evidentiary Q1: N=287 patients; of the 76 patients with ABCD scores ≤3, 0 (0%; 95% CI 0 to 5) had 7-or 30-day stroke, negative LR* 0 (95% CI 0 to 1.2); of the 58 patients with ABCD-I scores ≤3, 0 (0%; 95% CI 0 to 6) had 7-or 30-day stroke, negative LR* 0 (95% CI 0 to 1.6) Q2: N=274; ABCD 4 to 5 increases 30-day stroke risk; HR=4.1, 1.3 to 12.6; ischemic stroke occurred in 15 (5.5%) patients <30 days, 10 (3.6%) strokes occurring within 7 days, and 7 (2.6%) strokes occurring in 2 days; the ABCD-I score demonstrated minimally improved performance characteristics compared with the ABCD score in predicting 7-day stroke (OR for every point 2.68 vs 2.55) Q1: Potential for selection bias, given enrollment requirement of attending neurologist; unclear whether neurologists knew of or used the ABCD score during study, which could have led to treatment bias Q2: Excluded patients who did not have a CT in the ED and those who were lost to follow-up; all patients were evaluated by neurologists; relatively small sample size; unclear about the timing of the CT Evidentiary 
